|
1
|
Ouchi K and Sugiyama K: Required propofol
dose for anesthesia and time to emerge are affected by the use of
antiepileptics: Prospective cohort study. BMC Anesthesiol.
15:342015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nakanuno R, Yasuda T, Hamada H, Yoshikawa
H, Nakamura R, Saeki N and Kawamoto M: Propofol for anesthesia and
postoperative sedation resulted in fewer inflammatory responses
than sevoflurane anesthesia and midazolam sedation after
thoracoabdominal esophagectomy. Hiroshima J Med Sci. 64:31–37.
2015.PubMed/NCBI
|
|
3
|
Siampalioti A, Karavias D, Zotou A,
Kalfarentzos F and Filos K: Anesthesia management for the super
obese: Is sevoflurane superior to propofol as a sole anesthetic
agent? A double-blind randomized controlled trial. Eur Rev Med
Pharmacol Sci. 19:2493–2500. 2015.PubMed/NCBI
|
|
4
|
Chen Y, Liang M, Zhu Y and Zhou D: The
effect of propofol and sevoflurane on the perioperative immunity in
patients under laparoscopic radical resection of colorectal cancer.
Zhonghua Yi Xue Za Zhi. 95:3440–3444. 2015.(In Chinese). PubMed/NCBI
|
|
5
|
Inada T, Kubo K and Shingu K: Vaccines
using dendritic cells, differentiated with propofol, enhance
antitumor immunity in mice. Immunopharmacol Immunotoxicol.
31:150–157. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ji X and Cao SH: The influences of
propofol on corticosteroid and immunity of rats after hemorrhagic
shock and resuscitation. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue.
21:278–281. 2009.(In Chinese). PubMed/NCBI
|
|
7
|
Kushida A, Inada T and Shingu K:
Enhancement of antitumor immunity after propofol treatment in mice.
Immunopharmacol Immunotoxicol. 29:477–486. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vogel SN: How discovery of Toll-mediated
innate immunity in Drosophila impacted our understanding of TLR
signaling (and vice versa). J Immunol. 188:5207–5209. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Klein M, Obermaier B, Angele B, Pfister
HW, Wagner H, Koedel U and Kirschning CJ: Innate immunity to
pneumococcal infection of the central nervous system depends on
toll-like receptor (TLR) 2 and TLR4. J Infect Dis. 198:1028–1036.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Krejsek J, Kunes P, Andrýs C, Holická M,
Novosad J, Kudlová M and Kolácková M: Innate immunity, receptors
for exogenous and endogenous danger patterns in immunopathogenesis
of atherosclerosis-part II: TLR receptors, significance of genetic
polymorphism of danger signals receptors. Cas Lek Cesk Cesk
receptors, significance of genetic polymorphism of danger signals
receptors. Cas Lek Cesk. 144:790–794. 2005.(In Czech). PubMed/NCBI
|
|
11
|
Leavy O: Innate immunity: SHP regulates
TLR signalling. Nat Rev Immunol. 11:5022011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Levy O, Zarember KA, Roy RM, Cywes C,
Godowski PJ and Wessels MR: Selective impairment of TLR-mediated
innate immunity in human newborns: Neonatal blood plasma reduces
monocyte TNF-alpha induction by bacterial lipopeptides,
lipopolysaccharide, and imiquimod, but preserves the response to
R-848. J Immunol. 173:4627–4634. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
López CB, Moltedo B, Alexopoulou L,
Bonifaz L, Flavell RA and Moran TM: TLR-independent induction of
dendritic cell maturation and adaptive immunity by negative-strand
RNA viruses. J Immunol. 173:6882–6889. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zivkovic A, Sharif O, Stich K, Doninger B,
Biaggio M, Colinge J, Bilban M, Mesteri I, Hazemi P, Lemmens-Gruber
R and Knapp S: TLR 2 and CD14 mediate innate immunity and lung
inflammation to staphylococcal Panton-Valentine leukocidin in vivo.
J Immunol. 186:1608–1617. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chang G, Zhuang S, Seyfert HM, Zhang K, Xu
T, Jin D, Guo J and Shen X: Hepatic TLR4 signaling is activated by
LPS from digestive tract during SARA, and epigenetic mechanisms
contribute to enforced TLR4 expression. Oncotarget. 6:38578–38590.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma B, Dohle E, Li M and Kirkpatrick CJ:
TLR4 stimulation by LPS enhances angiogenesis in a co-culture
system consisting of primary human osteoblasts and outgrowth
endothelial cells. J Tissue Eng Regen Med. 11:1779–1791. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Płóciennikowska A, Hromada-Judycka A,
Borzęcka K and Kwiatkowska K: Co-operation of TLR4 and raft
proteins in LPS-induced pro-inflammatory signaling. Cell Mol Life
Sci. 72:557–581. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mannavola F, Tucci M, Felici C, Stucci S
and Silvestris F: miRNAs in melanoma: A defined role in tumor
progression and metastasis. Expert Rev Clin Immunol. 12:79–89.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen Z, Liu X, Hu Z, Wang Y, Liu M, Liu X,
Li H, Ji R, Guo Q and Zhou Y: Identification and characterization
of tumor suppressor and oncogenic miRNAs in gastric cancer. Oncol
Lett. 10:329–336. 2015.PubMed/NCBI
|
|
20
|
Xie F, Jones DC, Wang Q, Sun R and Zhang
B: Small RNA sequencing identifies miRNA roles in ovule and fibre
development. Plant Biotechnol J. 13:355–369. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shumin G, Yanfei D and Cheng Z: Role of
miRNA in plant seed development. Yi Chuan. 37:554–560. 2015.(In
Chinese). PubMed/NCBI
|
|
22
|
Rachagani S, Macha MA, Menning MS, Dey P,
Pai P, Smith LM, Mo YY and Batra SK: Changes in microRNA (miRNA)
expression during pancreatic cancer development and progression in
a genetically engineered KrasG12D; Pdx1-Cre mouse (KC) model.
Oncotarget. 6:40295–40309. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin Z, Lu J, Zhou W and Shen Y: Structural
insights into TIR domain specificity of the bridging adaptor Mal in
TLR4 signaling. PLoS One. 7:e342022012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ohnishi H, Tochio H, Kato Z, Orii KE, Li
A, Kimura T, Hiroaki H, Kondo N and Shirakawa M: Structural basis
for the multiple interactions of the MyD88 TIR domain in TLR4
signaling. Proc Natl Acad Sci USA. 106:pp. 10260–10265. 2009;
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rashidi N, Mirahmadian M, Jeddi-Tehrani M,
Rezania S, Ghasemi J, Kazemnejad S, Mirzadegan E, Vafaei S,
Kashanian M, Rasoulzadeh Z and Zarnani AH: Lipopolysaccharide- and
lipoteichoic acid-mediated pro-inflammatory cytokine production and
modulation of TLR2, TLR4 and MyD88 expression in human endometrial
cells. J Reprod Infertil. 16:72–81. 2015.PubMed/NCBI
|
|
27
|
Bamford S, Ryley H and Jackson SK: Highly
purified lipopolysaccharides from Burkholderia cepacia complex
clinical isolates induce inflammatory cytokine responses via
TLR4-mediated MAPK signalling pathways and activation of NFkappaB.
Cell Microbiol. 9:532–543. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Calil IL, Zarpelon AC, Guerrero AT,
Alves-Filho JC, Ferreira SH, Cunha FQ, Cunha TM and Verri WA Jr:
Lipopolysaccharide induces inflammatory hyperalgesia triggering a
TLR4/MyD88-dependent cytokine cascade in the mice paw. PLoS One.
9:e900132014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sharma J, Mishra BB, Li Q and Teale JM:
TLR4-dependent activation of inflammatory cytokine response in
macrophages by Francisella elongation factor Tu. Cell Immunol.
269:69–73. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ma J, Xiao W, Wang J, Wu J, Ren J, Hou J,
Gu J, Fan K and Yu B: Propofol inhibits NLRP3 inflammasome and
attenuates blast-induced traumatic brain injury in rats.
Inflammation. 39:2094–2103. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang J, Jiang H, Wang J, Zhao Y, Zhu Y and
Zhu M: Propofol attenuates high glucose-induced superoxide anion
accumulation in human umbilical vein endothelial cells. Fundam Clin
Pharmacol. 30:511–516. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu F, Chen MR, Liu J, Zou Y, Wang TY, Zuo
YX and Wang TH: Propofol administration improves neurological
function associated with inhibition of pro-inflammatory cytokines
in adult rats after traumatic brain injury. Neuropeptides. 58:1–6.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yan LX, Liu YH, Xiang JW, Wu QN, Xu LB,
Luo XL, Zhu XL, Liu C, Xu FP, Luo DL, et al: PIK3R1 targeting by
miR-21 suppresses tumor cell migration and invasion by reducing
PI3K/AKT signaling and reversing EMT, and predicts clinical outcome
of breast cancer. Int J Oncol. 48:471–484. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang J, Jiao J, Cermelli S, Muir K, Jung
KH, Zou R, Rashid A, Gagea M, Zabludoff S, Kalluri R and Beretta L:
miR-21 inhibition reduces liver fibrosis and prevents tumor
development by inducing apoptosis of CD24+ progenitor
cells. Cancer Res. 75:1859–1867. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dong G, Liang X, Wang D, Gao H, Wang L,
Wang L, Liu J and Du Z: High expression of miR-21 in
triple-negative breast cancers was correlated with a poor prognosis
and promoted tumor cell in vitro proliferation. Med Oncol.
31:572014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiang LH, Ge MH, Hou XX, Cao J, Hu SS, Lu
XX, Han J, Wu YC, Liu X, Zhu X, et al: miR-21 regulates tumor
progression through the miR-21-PDCD4-Stat3 pathway in human
salivary adenoid cystic carcinoma. Lab Invest. 95:1398–1408. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kang WK, Lee JK, Oh ST, Lee SH and Jung
CK: Stromal expression of miR-21 in T3-4a colorectal cancer is an
independent predictor of early tumor relapse. BMC Gastroenterol.
15:22015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu C, Li B, Cheng Y, Lin J, Hao J, Zhang
S, Mitchel RE, Sun D, Ni J, Zhao L, et al: MiR-21 plays an
important role in radiation induced carcinogenesis in BALB/c mice
by directly targeting the tumor suppressor gene Big-h3. Int J Biol
Sci. 7:347–363. 2011. View Article : Google Scholar : PubMed/NCBI
|
